Newsletter | March 26, 2024

03.26.24 -- What Proposed Plasmid DNA Standards Say For GMP/Non-GMP Production

FEATURED EDITORIAL

What Proposed Plasmid DNA Standards Say For GMP/Non-GMP Production

Today’s standards for plasmid DNA production lack specificity, and manufacturers have been clamoring for more. In late 2023, USP published draft General Chapter <1040> to help fill in the cracks. 

INDUSTRY INSIGHTS

How Modern Software Architecture Is Revolutionizing IRT Solutions

Explore the ways technology suppliers across the clinical trial space have begun investing in IRTs built around a microservices model capable of improving data access and visibility.

Pharma’s Frozen Assets

Delve into a data-driven approach to assess the volume and value of cold chain medicines by combining IQVIA audit data with publicly available data.

A Happy And Unhappy Supply Chain Experience

Tony Sampognaro, Director, CMC Project Management, Stoke Therapeutics, recalls a rather harrowing experience involving a CMO and Clinical Operations failure to communicate.

Is Your Clinical Supply Chain Fully Optimized?

Streamlined supply chain operations alleviate staff workload and significantly reduce IP waste. With the right partners, you can create a fully optimized, cost-effective supply chain strategy.

SOLUTIONS

Understanding Options In Direct-To-Patient Clinical Supply

Finishing Services: Labeling, Secondary Packaging, And Kitting